We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$2.52B
AUM Growth
+$249M
Cap. Flow
+$45.6M
Cap. Flow %
1.81%
Top 10 Hldgs %
28.16%
Holding
266
New
9
Increased
91
Reduced
111
Closed
9

Sector Composition

Rank Sector Weight
1 Financials 18.37%
2 Technology 17.39%
3 Healthcare 10.53%
4 Consumer Discretionary 8.32%
5 Consumer Staples 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJK icon
126
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$1.2M 0.05%
20,136
-232
-1% -$13.3K
IWO icon
127
iShares Russell 2000 Growth ETF
IWO
$14.4B
$1.19M 0.05%
5,564
-137
-2% -$27.8K
SCHF icon
128
Schwab International Equity ETF
SCHF
$65.5B
$1.19M 0.05%
70,670
+2,080
+3% +$34.2K
IVW icon
129
iShares S&P 500 Growth ETF
IVW
$71.9B
$1.13M 0.04%
23,332
-40
-0.2% -$1.85K
MO icon
130
Altria Group
MO
$125B
$1.13M 0.04%
22,579
-832
-4% -$39.2K
SPHQ icon
131
Invesco S&P 500 Quality ETF
SPHQ
$19.3B
$1.11M 0.04%
30,362
+418
+1% +$14.6K
AMGN icon
132
Amgen
AMGN
$212B
$1.1M 0.04%
4,557
-160
-3% -$35.3K
TMO icon
133
Thermo Fisher Scientific
TMO
$214B
$1.04M 0.04%
3,203
-63
-2% -$19.1K
BA icon
134
Boeing
BA
$175B
$1.04M 0.04%
3,192
-431
-12% -$153K
XLF icon
135
State Street Financial Select Sector SPDR ETF
XLF
$57.4B
$1.01M 0.04%
32,939
-637
-2% -$18.7K
ULTA icon
136
Ulta Beauty
ULTA
$21.6B
$989K 0.04%
3,905
-1,056
-21% -$258K
XLK icon
137
State Street Technology Select Sector SPDR ETF
XLK
$112B
$978K 0.04%
21,340
-664
-3% -$28.4K
EDIT icon
138
Editas Medicine
EDIT
$402M
$970K 0.04%
32,775
-19,425
-37% -$485K
SPIB icon
139
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$964K 0.04%
27,289
-2,775
-9% -$97.8K
NVDA icon
140
NVIDIA
NVDA
$4.77T
$916K 0.04%
155,720
+18,520
+13% +$96.3K
MDLZ icon
141
Mondelez International
MDLZ
$80.2B
$878K 0.03%
15,947
-250
-2% -$13.4K
IWD icon
142
iShares Russell 1000 Value ETF
IWD
$82.2B
$866K 0.03%
6,349
GILD icon
143
Gilead Sciences
GILD
$167B
$821K 0.03%
12,632
-1,271
-9% -$82.8K
PBCT
144
DELISTED
People's United Financial Inc
PBCT
$801K 0.03%
47,400
-300
-0.6% -$4.92K
GE icon
145
GE Aerospace
GE
$377B
$797K 0.03%
14,324
-884
-6% -$45.7K
AXP icon
146
American Express
AXP
$227B
$788K 0.03%
6,333
NSC icon
147
Norfolk Southern
NSC
$76.1B
$785K 0.03%
4,045
-100
-2% -$18.8K
ABBV icon
148
AbbVie
ABBV
$465B
$772K 0.03%
8,722
+200
+2% +$16.6K
SHY icon
149
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$765K 0.03%
9,045
+1,016
+13% +$86.1K
CM icon
150
Canadian Imperial Bank of Commerce
CM
$109B
$764K 0.03%
18,372

Similar funds

Crestwood Advisors Group's Q4 2019 Portfolio in Review

As of Q4 2019, Crestwood Advisors Group held 266 positions worth $2.52B, up 11% from $2.27B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Crestwood Advisors Group's Q4 2019 filing shows 9 new, 91 increased, 111 reduced and 9 closed positions. Its largest new stake was Cue Biopharma: 9,000 shares worth $4.29M. The largest sale was EOG Resources, an estimated $2.94M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Crestwood Advisors Group's largest Q4 2019 buy was Cue Biopharma: 9,000 shares worth $4.29M.
  • Crestwood Advisors Group added most to iShares Core S&P Small-Cap ETF in Q4 2019, an estimated $13.7M increase.
  • Crestwood Advisors Group's biggest Q4 2019 reduction was EOG Resources, cutting an estimated $2.94M.
  • Crestwood Advisors Group fully exited Celgene Corp in Q4 2019, selling an estimated $720K.
  • Crestwood Advisors Group's ten largest holdings make up 28% of its $2.52B portfolio in Q4 2019.
  • Crestwood Advisors Group opened 9 new positions and closed 9 in Q4 2019.
  • Crestwood Advisors Group's portfolio value rose 11% quarter-over-quarter to $2.52B.

Based on Crestwood Advisors Group's 13F filing for Q4 2019, filed 12 Feb 2020.